Research and prospect of biotherapy and cell therapy in severe liver diseasesZANG Hong, YOU Shao-li, XIN Shao-jie331-333
Down-regulation effect of HBV genome pre-S deletion mutation on viral replication capacity and the transcriptional activity of the overlapping surface antigen promoterⅡMIAO Fu-zhen, XU Zhi-hui, LIU Yan, LI Qi, LI Xiao-dong, YAO Wei-ming, XIN Shao-jie, LI Jin, XU Dong-ping334-338
rtA181S mutation in the reverse-transcriptase domain of HBV is associated with adefovir dipivoxil resistanceYANG Jing, LIU Yan, CHEN Rong-juan, XU Zhi-hui, CHEN Li, XIN Shao-jie, LIU Xin-guang, XU Dong-ping339-342
Expression of myeloid-derived suppressor cells in peripheral blood in patients with HBV-related acute-on-chronic liver failureLI Chen, LIU Hong-ling, ZANG Hong, ZHU Bing, CHEN Jing, LIU Wan-shu, YOU Shao-li, XIN Shao-jie343-347,357
Association between serum levels and single nucleotide polymorphisms of CXCL10 and thyroid dysfunction in patients with chronic hepatitis CSHAO Cui-ping, HUO Na, FAN Xiao-hong, ZHENG Ying-ying, BAO Yi, LI Fang, LI Min-ran, LU Hai-ying, XU Xiao-yuan348-350,354
Inhibition of the activation of nuclear factor kappa-light-chain-enhancer of activated B cells by M fragments of new type of reovirusBAI Bing-ke, TAO Ling, SHEN Hong-hui, HOU Jun, HU Yan, LUO Sheng-dong, YANG Rui-chuang, MAO Pan-yong351-354
Clinical significance of quantitative detection of Brucella DNA in serum samplesZHENG Wen-yan, ZHANG Ju-ling, ZHANG Zhuan-cai, YAN Fei, QU Fen355-357
Retrospective analysis of the effect of nucleoside analogues on HBV reactivation due to glucocorticoid therapyXIA Xu-hui, CHEN Xin358-361